Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
AMLX
↓ PDF (Pro)Amylyx Pharmaceuticals Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericNASDAQ
$16.18
-1.67%today
MKT CAP
$1.8B
-4.4% · 1Y
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership-
Institutional Ownership-
Short % of Float-
Days to Cover-
1 Week-0.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| PRGO | $1.7B | 100 | - | 5.0 | - | - | - | - | 990.00% |
| ANIP | $1.9B | 73 | 25.3 | 7.9 | - | - | - | - | 0.00% |
| BHC | $2.1B | 100 | - | 1.4 | - | - | - | - | 0.00% |
| HROW | $1.5B | 80 | - | 14.8 | - | - | - | - | 0.00% |
| BCRX | $2.3B | 80 | - | 11.7 | - | - | - | - | 0.00% |
| HCM | $2.3B | 67 | 5.0 | 25.5 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for AMLX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.